Stockscreener 앱 받기
8.89
1.25%
0.11
시간 외 거래:
8.88
-0.010
-0.11%
Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스
(PHAT) Proactive Strategies - Stock Traders Daily
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2024 Earnings Call Transcript - Insider Monkey
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Up 115.60% This Year: What Is Going To Happen Next - Stocks Register
Phathom Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Business Updates - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 8.9%Here's What Happened - MarketBeat
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue Estimates - MSN
Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlig - GuruFocus.com
Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Phathom Pharmaceuticals Reports Significant Revenue Growth - TipRanks
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Previ - GuruFocus.com
Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
Jennison Associates LLC's Strategic Acquisition in Phathom Pharm - GuruFocus.com
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire
Investors bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m despite increasing losses YoY, taking one-year return to 96% - Yahoo Finance
Phathom Pharmaceuticals (PHAT) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
PHAT SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action InvestigationPHAT - Marketscreener.com
Phathom Pharmaceuticals to Report Third Quarter 2024 - GlobeNewswire
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business - The Bakersfield Californian
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024 - StockTitan
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the - GlobeNewswire
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting - Yahoo Finance
Where are the Opportunities in (PHAT) - Stock Traders Daily
Some of the Gastroesophageal Reflux Disease Therapeutics market players are: - InsightAce Analytic
Shareholders have faith in loss-making Phathom Pharmaceuticals (NASDAQ:PHAT) as stock climbs 6.6% in past week, taking one-year gain to 74% - Simply Wall St
Creative Planning Has $278,000 Stock Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 6.8%Time to Buy? - MarketBeat
Certain Common Stock of Phathom Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-OCT-2024. - Marketscreener.com
Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily
A year in review: Phathom Pharmaceuticals Inc (PHAT)’s performance in the last year - US Post News
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 3.4%Time to Sell? - MarketBeat
PHAT’s 52-Week Rollercoaster: From $6.07 to $19.71 – What’s Next for Investors? - The InvestChronicle
Financial Health Report: Phathom Pharmaceuticals Inc (PHAT)’s Ratios Tell a Tale - The Dwinnex
Learn to Evaluate (PHAT) using the Charts - Stock Traders Daily
A stock that deserves closer examination: Phathom Pharmaceuticals Inc (PHAT) - US Post News
PHAT Stock Sees Decline of Approximately -13.44% in Last Five Days - Knox Daily
PHAT Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.5%Here's What Happened - MarketBeat
Daily Market Movement: Phathom Pharmaceuticals Inc (PHAT) Sees a -4.96 Decrease, Closing at 17.25 - The Dwinnex
A new trading data show Phathom Pharmaceuticals Inc (PHAT) is showing positive returns. - SETE News
Marshall Wace LLP Invests $1.16 Million in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat
Phathom Pharmaceuticals Inc Inc. (PHAT) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 4.8%Here's Why - MarketBeat
The Potential Rise in the Price of Phathom Pharmaceuticals Inc (PHAT) following insiders activity - Knox Daily
Have you been able to find a good deal on Phathom Pharmaceuticals Inc’s shares? - US Post News
Phathom Pharmaceuticals Inc (PHAT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Its Stock Has Paid Off Big Time For Phathom Pharmaceuticals Inc - SETE News
Phathom Pharmaceuticals Inc (PHAT)’s stock chart: A technical perspective - US Post News
Phathom's Voquezna: A Breakthrough Drug Facing Marketing Challenges (NASDAQ:PHAT) - Seeking Alpha
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) - PR Newswire
Federated Hermes Inc. Cuts Stock Holdings in Hilton Grand Vacations Inc. (NYSE:HGV) - Defense World
Dimensional Fund Advisors LP Grows Stock Position in Koninklijke Philips (NYSE:PHG) - MarketBeat
Rhumbline Advisers Has $710,000 Stock Holdings in Koninklijke Philips (NYSE:PHG) - Defense World
Philips Must Face Investor Suit Over FDA Compliance Issues - Law360
PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily
3.66%
1.11%
자본화:
|
볼륨(24시간):